Trump administration relaxes medical marijuana regulations nationwide

The Trump Administration Has Reclassified Medical Marijuana as a Less-Dangerous Drug

In a recent move, the Trump administration has reclassified state-licensed medical marijuana as a less-dangerous drug. This change is part of a broader effort to ease restrictions on certain categories of marijuana.

According to reports, the Justice Department has made this classification under the Controlled Substances Act. The new classification will affect the way marijuana is regulated and used for medical purposes.

The reclassification applies to specific types of marijuana that are currently classified as Schedule I substances. These substances are considered to have a high potential for abuse and no accepted medical use.

The change in classification is intended to provide more flexibility for researchers, manufacturers, and patients who rely on marijuana for medicinal purposes. However, the exact details of the new classification and its implications remain unclear.

The reclassification has been met with mixed reactions from various stakeholders, including lawmakers and advocacy groups. Some have expressed concerns about the potential consequences of this change, while others see it as a step towards greater medical freedom.

As the administration continues to implement this policy change, further information will become available on how it will be enforced and what impact it may have on the medical marijuana industry.

Source: Google News World